1. Home
  2. BLBD vs CERT Comparison

BLBD vs CERT Comparison

Compare BLBD & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blue Bird Corporation

BLBD

Blue Bird Corporation

HOLD

Current Price

$57.79

Market Cap

1.7B

ML Signal

HOLD

CERT

Certara Inc.

HOLD

Current Price

$7.16

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLBD
CERT
Founded
1927
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Construction/Ag Equipment/Trucks
Retail: Computer Software & Peripheral Equipment
Sector
Consumer Discretionary
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.1B
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
BLBD
CERT
Price
$57.79
$7.16
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$67.20
$12.22
AVG Volume (30 Days)
495.0K
3.2M
Earning Date
05-11-2026
05-28-2026
Dividend Yield
N/A
N/A
EPS Growth
22.78
87.50
EPS
0.94
N/A
Revenue
$1,480,099,000.00
$418,838,000.00
Revenue This Year
$4.25
$8.29
Revenue Next Year
$4.21
$7.68
P/E Ratio
$61.82
N/A
Revenue Growth
9.87
8.75
52 Week Low
$30.15
$6.04
52 Week High
$62.90
$15.38

Technical Indicators

Market Signals
Indicator
BLBD
CERT
Relative Strength Index (RSI) 53.02 41.10
Support Level $53.58 N/A
Resistance Level $58.57 $11.53
Average True Range (ATR) 2.53 0.39
MACD -0.32 0.10
Stochastic Oscillator 28.48 78.76

Price Performance

Historical Comparison
BLBD
CERT

About BLBD Blue Bird Corporation

Blue Bird Corp is an American bus manufacturing company. It is an independent designer and manufacturer of school buses. The company operates in two segments; the Bus segment which involves the design, engineering, manufacture, and sales of school buses and extended warranties; and the Parts segment which includes the sales of replacement bus parts. Geographically, the company generates a majority of its revenue from its customers in the United States and the rest from Canada and Rest of the world.

About CERT Certara Inc.

Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.

Share on Social Networks: